We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
all report title image
  • Published On : Sep 2022
  • Code : CMI5257
  • Pages :237
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Vitamins and minerals are essential nutrients which get from eating a healthy however, Advisory Committee on Borderline Substances (ACBS) committee recommended vitamins and minerals to management actual or potential vitamin or mineral deficiency. Thus, an increase in spending on vitamins and minerals products is expected to drive the growth of market. For instance, according to PrescQIPP in England, approximately US$ 4.7 million is spent annually on the prescribing of vitamins and minerals products.

The global vitamin and mineral supplement tablets market is estimated to be valued at US$ 14,770.6 million in 2022 and is expected to exhibit a CAGR of 4.6% during the forecast period (2022-2030).

Figure 1. Global Vitamin and Mineral Supplement Tablets Market in Terms of Value (US$ million), By Region, 2022

VITAMIN AND MINERAL SUPPLEMENT TABLETS MARKET

To learn more about this report, request a free sample copy

Increase in consumption of vitamins and minerals supplement tablets is expected to drive the global vitamin and mineral supplement tablets market growth during the forecast period.

Vitamins and minerals play an important role in performing body function, boosting the immune system, and supporting normal growth and development. Smoking, poor nutrition, and excessive intake of alcohol lead to weakening the immune system. This is contribute to surge in consumption of vitamins and minerals and thereby drives the growth of market. For instance, according to National Stem Cell Foundation (NSCF), globally, approximately 4% of the population is affected by one of more than 80 different autoimmune diseases and in the U.S., autoimmune diseases represent the third most common cause of chronic illness.

Vitamin and Mineral Supplement Tablets Market Report Coverage

Report Coverage Details
Base Year: 2021 Market Size in 2022: US$ 14,770.6 Mn
Historical Data for: 2017 to 2020 Forecast Period: 2022 to 2030
Forecast Period 2022 to 2030 CAGR: 4.6% 2030 Value Projection: US$ 21,166.6 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Type: Vitamins ( Vitamin A, Vitamin C, Vitamin D, Vitamin E, Vitamin K, Vitamin B), Minerals (Calcium, Copper, Magnesium, Potassium, Others)
  • By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, E-stores
Companies covered:

Otsuka Pharmaceutical Co., Ltd., NutraScience Labs, Glanbia plc, Herbalife Nutrition, Abbott, Amway, Bayer AG, GlaxoSmithKline plc, NSE, inc. Company, Bactolac Pharmaceutical, Inc., Nature's Way Products, LLC, Noreva Biotech, Pharmavite, Brunel Healthcare, HTC Health

Growth Drivers:
  • Raising awareness regarding  health
  • Increase in consumption of vitamins and minerals
Restraints & Challenges:
  • Stringent regulations

Figure 2. Global Vitamin and Mineral Supplement Tablets Market Share (%), By Type, 2022

VITAMIN AND MINERAL SUPPLEMENT TABLETS MARKET

To learn more about this report, request a free sample copy

Increase in awareness regarding the health is expected to drive the global vitamin and mineral supplement tablets market growth over the forecast period.

Consumers are more aware of their health and wellbeing. The consumer’s priorities are shifting towards taking care of their wellbeing, and this has stimulated the growth of the vitamins and minerals supplements sector.

Global Vitamin and Mineral Supplement Tablets Market – Impact of Coronavirus (COVID-19) Pandemic

COVID-19 caused several challenges to manufacture, supply and distribute vitamins and minerals supplement tablets. It has significantly affected healthcare systems and economies within a short timeframe. COVID-19 pandemic leads to put many more individuals at risk of food insecurity and make consuming a healthy diet even more difficult. This is contribute to increase in consumers demand for vitamins and minerals supplements products to support their immune health and boost overall wellness

Global Vitamin and Mineral Supplement Tablets Market: Restraints

Stringent rules and regulations by government authorities are responsible to delay in product approval. The vitamins and minerals products must undergo testing Dietary Supplements Health and Education Act of 1994  which results in the procedural delay. This, in turn, hampers the growth of market. The Dietary Supplement Health and Education Act of 1994 is a 1994 statute of United States Federal legislation which defines and regulates dietary supplements. Under the act

Key Players                   

Major players operating in the global vitamin and mineral supplement tablets market include Otsuka Pharmaceutical Co., Ltd., NutraScience Labs, Glanbia plc, Herbalife Nutrition, Abbott, Amway, Bayer AG, GlaxoSmithKline plc, NSE, inc. Company, Bactolac Pharmaceutical, Inc., Nature's Way Products, LLC, Noreva Biotech, Pharmavite, Brunel Healthcare, and HTC Health.

Frequently Asked Questions

The global vitamin and mineral supplement tablets market is estimated to be valued at US$ 14,770.6 million in 2022 and is expected to exhibit a CAGR of 4.6% between 2022 and 2030.

Raising awareness about health is expected to drive the global vitamin and mineral supplement tablets market growth over the forecast period.

Vitamins segment is hold a major market share in the market.

The major factor hampering growth of the tablets market include stringent regulations.

Major players operating in the market include Otsuka Pharmaceutical Co., Ltd., NutraScience Labs, Glanbia plc, Herbalife Nutrition, Abbott, Amway, Bayer AG, GlaxoSmithKline plc, NSE, inc. Company, Bactolac Pharmaceutical, Inc., Nature's Way Products, LLC, Noreva Biotech, Pharmavite, Brunel Healthcare, and HTC Health.

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now

Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Request Discount
Logo

Reliability and Reputation

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Reliability and Reputation

27001:2022

Reliability and Reputation

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo